A new FcεRI receptor-mimetic peptide (PepE) that blocks IgE binding to its high affinity receptor and prevents mediator release from RBL 2H3 cells

被引:7
作者
Sandomenico, Annamaria [1 ]
Monti, Simona M. [1 ]
Palumbo, Rosanna [1 ]
Ruvo, Menotti [1 ]
机构
[1] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy
关键词
IgE; allergy; Fc epsilon RI; SPR; histamine release; DEGRANULATING MCD PEPTIDE; CRYSTAL-STRUCTURE; INHIBITORS; RESIDUES; ALPHA; SITE;
D O I
10.1002/psc.1368
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have recently reported on a class of IgE-binding peptides designed based on the crystallographic structure of the high affinity Fc epsilon RI. Peptides contain receptor key residues located within the two distinct binding sites for IgE and selectively bind IgE with an affinity ranging between 6 and 60 mu M. We have here designed and characterized a new molecule containing the receptor loops C'-E and B-C and an optimized linker for joining them made of a Lys side chain and a beta-Ala. This new peptide shows an increased affinity (around 30 times) compared to the parent loop C'-E + B-C previously described, while retaining the same two-site mechanism of binding and the same selectivity. It also blocks the binding of IgE to the cell-anchored receptor and efficiently prevents histamine release from mast cells. These properties make the peptide a useful scaffold for the development of new anti-allergic drugs. Copyright (C) 2011 European Peptide Society and John Wiley & Sons, Ltd.
引用
收藏
页码:604 / 609
页数:6
相关论文
共 29 条
[1]   Mast cell degranulating (MCD) peptide: a prototypic peptide in allergy and inflammation [J].
Buku, A .
PEPTIDES, 1999, 20 (03) :415-420
[2]   [Ala12]MCD peptide:: a lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors [J].
Buku, A ;
Condie, BA ;
Price, JA ;
Mezei, M .
JOURNAL OF PEPTIDE RESEARCH, 2005, 66 (03) :132-137
[3]   Partial alanine scan of mast cell degranulating peptide (MCD): Importance of the histidine- and arginine residues [J].
Buku, A ;
Mendlowitz, M ;
Condie, BA ;
Price, JA .
JOURNAL OF PEPTIDE SCIENCE, 2004, 10 (06) :313-317
[4]   Histamine-releasing activity and binding to the FcεRIα human mast cell receptor subunit of mast cell degranulating peptide analogues with alanine substitutions [J].
Buku, A ;
Mendlowitz, M ;
Condie, BA ;
Price, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (14) :3008-3012
[5]   Further studies on the structural requirements for mast cell degranulating (MCD) peptide-mediated histamine release [J].
Buku, A ;
Price, JA .
PEPTIDES, 2001, 22 (12) :1987-1991
[6]   Mast cell degranulating peptide binds to RBL-2H3 mast cell receptors and inhibits IgE binding [J].
Buku, A ;
Price, JA ;
Mendlowitz, M ;
Masur, S .
PEPTIDES, 2001, 22 (12) :1993-1998
[7]   Effective mast cell degranulating peptide inhibitors of the IgE/FcεRI receptor interaction [J].
Buku, Angeliki ;
Keselman, Inna ;
Lupyan, Dmitry ;
Mezei, Mihaly ;
Price, Joseph A. .
CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 72 (02) :133-139
[8]   Identification of contact residues in the IgE binding site of human FcεRIα [J].
Cook, JPD ;
Henry, AJ ;
McDonnell, JM ;
Owens, RJ ;
Sutton, BJ ;
Gould, HJ .
BIOCHEMISTRY, 1997, 36 (50) :15579-15588
[9]   The alliance of genes and environment in asthma and allergy [J].
Cookson, W .
NATURE, 1999, 402 (6760) :B5-B11
[10]   Safety and tolerability of omalizumab [J].
Corren, J. ;
Casale, T. B. ;
Lanier, B. ;
Buhl, R. ;
Holgate, S. ;
Jimenez, P. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (06) :788-797